Stories of a 'new' ageing population gathered for the first time

January 14, 2014, King's College London

Researchers at King's College London have called on politicians to review the cost of prescriptions for liver transplant recipients, who must take daily immunosuppressants to prevent organ rejection for the rest of their lives. For the first time a suite of personal narratives from an emerging 'new' ageing population have been gathered from the surviving members of the first cohort of paediatric liver transplant recipients, who received their transplant up to 30 years ago at Addenbrooke's or King's College Hospital.

The narratives have highlighted again the requirement for young adults living in England to pay ongoing prescription charges for their drugs, including vital immunosuppressants as well as other medications over their lifetime. Dr Karen Lowton, from the Department of Social Science, Health and Medicine, who led the study, said: 'The cost of prescriptions we believe is unjust for our participants and all others growing up and growing older with a transplant. The issue of exemption for people with long-term conditions in paying for the prescriptions has been raised before, most recently by Prof Ian Gilmore in his report for the Secretary of State for Health in 2009, but we were struck through the participants' stories by how government legislation has not caught up with how a small but significant part of our society live their lives.

'When the prescription exemption list for adults was drawn up in 1968, transplant expertise and had not been developed, and children with rare and complex liver disease, who would have received free prescriptions when children, did not survive to adulthood; there was no reason therefore to exempt them. Forty-five years later this is not the case for most adults receiving their post-transplant healthcare in England, despite their increasing numbers.'

The examination of the lives and experiences revealed insights into a 'new' population not previously expected to survive. The researchers were surprised to find that 90% of participants reported not knowing any other adult who had had the procedure in childhood, a contrast to the way other long-term conditions are managed in society.

Dr Lowton said: 'Talking to others in the same situation can be helpful to overcome feelings of isolation or 'being the only one', but this has not happened for these now-adult recipients. Patients who identify and converse with others with the same condition are able to share tips for living with rare and long-term conditions.'

As part of their study, the team from King's hosted a lunch for participants to enable them to meet other adults who share their liver-recipient status for the first time.

The collection of accounts from participants revealed lives lived within in bodies viewed as a physical and social 'project'. The adult survivors form a group of adults who have lived their whole lives in the context of their then experimental or innovative surgery. Whilst the study found participants recount many of the usual anxieties and challenges of growing up, the status of the participants as pioneers is clear as there is no cohort ahead of them who have had the same procedure to provide advice based on experience.

Other key themes to emerge from participants' narratives included 'the public's reaction', the use of alcohol, being 'different', managing uncertainty and using health services. The issue of the transplant arose in the stories of all participants. Early liver transplant surgery left participants with a large scar; the incision made for today's paediatric liver transplants is now slightly smaller but is still a significant mark on the body.

Dr Lowton said: 'Surprisingly, current clinical practice guidelines for long term medical management of children post paediatric liver transplant do not refer to the scar at all, and instead focus on health-related considerations such as symptom monitoring, blood tests and immunosuppression. However, we found that this scar has a long and complex life and is of considerable significance to liver recipients.'

The most common significance of the scar was as a physical manifestation of what recipients had been through in terms of their health and treatment and as a reminder of how close they had been to death. Participants spoke in terms of heroic survival. They also spoke of their scar being a mark of respect to the donor who had given the 'gift of life' to them. Further, they expressed feelings of a moral obligation to not just observe life going by, but to live life 'well', although how this was interpreted differed between participants.

Dr Lowton said: 'The encouraging strand to emerge from ' stories was what a full life all those who had received a liver transplant in childhood were living, despite quite a wide range of physical abilities and ongoing health problems. This research not only highlights the ongoing health and social concerns of those growing older with one of the first childhood in the UK, but also the continuing need for donors for those waiting on the transplant list.'

Explore further: Kidney failure can complicate long-term outcomes in children receiving solid-organ transplants

Related Stories

Kidney failure can complicate long-term outcomes in children receiving solid-organ transplants

October 14, 2013
Children who undergo transplants of solid organs have a high risk of developing advanced kidney disease, according to a new national study. Among these children, the highest risk is in those receiving lung or intestinal transplants, ...

Liver transplant survival rates lower in black than white pediatric patients

December 5, 2013
Novel research reveals racial and socioeconomic disparities among pediatric liver transplant patients. Findings published in Liver Transplantation, a journal of the American Association for the Study of Liver Diseases and ...

Exercise may reduce heart disease risk in liver transplant recipients

August 6, 2013
New research reveals that metabolic syndrome—risk factors that can lead to heart disease and/or stroke—is common in liver transplant recipients, with rates highest at one year following the procedure. Findings published ...

Alcoholism treatment before, after liver transplantation reduces relapse

October 3, 2013
New research reports that liver transplant recipients who receive substance abuse treatment before and after transplantation have much lower alcohol relapse rates than those untreated or only treated prior to transplantation. ...

Liver transplant recipients' cancer risk

October 10, 2013
Liver transplant recipients are more susceptible to cancer, especially skin cancers, new Flinders University research shows.

Could deceased heart attack victims expand donor pool?

November 11, 2013
Researchers from the U.K. suggest that using organs from donors after circulatory death (DCD) who also suffered a previous cardiac arrest out of the hospital environment could expand the pool of available livers for transplant. ...

Recommended for you

Best of Last Year—The top Medical Xpress articles of 2017

December 20, 2017
It was a good year for medical research as a team at the German center for Neurodegenerative Diseases, Magdeburg, found that dancing can reverse the signs of aging in the brain. Any exercise helps, the team found, but dancing ...

Pickled in 'cognac', Chopin's heart gives up its secrets

November 26, 2017
The heart of Frederic Chopin, among the world's most cherished musical virtuosos, may finally have given up the cause of his untimely death.

Sugar industry withheld evidence of sucrose's health effects nearly 50 years ago

November 21, 2017
A U.S. sugar industry trade group appears to have pulled the plug on a study that was producing animal evidence linking sucrose to disease nearly 50 years ago, researchers argue in a paper publishing on November 21 in the ...

Female researchers pay more attention to sex and gender in medicine

November 7, 2017
When women participate in a medical research paper, that research is more likely to take into account the differences between the way men and women react to diseases and treatments, according to a new study by Stanford researchers.

Drug therapy from lethal bacteria could reduce kidney transplant rejection

August 3, 2017
An experimental treatment derived from a potentially deadly microorganism may provide lifesaving help for kidney transplant patients, according to an international study led by investigators at Cedars-Sinai.

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.